Pandolfi F, Pierdominici M, Oliva A, D'Offizi G, Mezzaroma I, Mollicone B, Giovannetti A, Rainaldi L, Quinti I, Aiuti F
Department of Allergy and Clinical Immunology, La Sapienza University of Rome, Italy.
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 15;9(5):450-8.
Peripheral blood mononuclear cells (PBMC) from 103 HIV-infected patients were tested for their mortality rate (MR) when incubated in vitro for 3 days in a culture medium. MR was related to apoptosis as shown by DNA analysis and morphological evaluation of ethidium bromide-stained PBMC by flow cytometry. MR was significantly higher in patients in CDC stage IV as compared to patients in stage II or III (p = 0.017). MR was also higher in patients with low CD4 cells/mm3 (p = 0.014 for patients with < 400 cells; p = 0.001 for patients with < 200 CD4 cells/mm3) and with low percentage of CD4 cells (p = 0.001 for patients with < 10% of CD4 cells). A significant negative correlation was observed between MR and both absolute numbers or percentages of CD4 cells (p < 0.001). The addition of interleukin-2 (IL-2) and fibro-blast-conditioned medium (FCM) to the cultures significantly reduced MR. However, the ability of both IL-2 and FCM to preserve viability was significantly associated with p24 negativity. Clinical and immunological follow-up was available for 60 patients for a mean period of 26 months. MR at the beginning of the study was significantly higher in the group of patients who clinically progressed (according to the CDC classification) or died during the follow-up (p < 0.0001). Our data suggest that MR correlates with both disease severity and progression and that MR is directly related to the depletion of CD4 cells in cultures.(ABSTRACT TRUNCATED AT 250 WORDS)
对103例HIV感染患者的外周血单个核细胞(PBMC)在培养基中进行体外培养3天,检测其死亡率(MR)。DNA分析以及通过流式细胞术对溴化乙锭染色的PBMC进行形态学评估显示,MR与细胞凋亡相关。与疾病控制中心(CDC)II期或III期患者相比,IV期患者的MR显著更高(p = 0.017)。CD4细胞/mm³ 数量低的患者MR也更高(CD4细胞<400个/mm³ 的患者,p = 0.014;CD4细胞<200个/mm³ 的患者,p = 0.001),且CD4细胞百分比低的患者MR也更高(CD4细胞<10%的患者,p = 0.001)。观察到MR与CD4细胞的绝对数量或百分比均呈显著负相关(p < 0.001)。向培养物中添加白细胞介素-2(IL-2)和成纤维细胞条件培养基(FCM)可显著降低MR。然而,IL-2和FCM维持细胞活力的能力均与p24阴性显著相关。6往0例患者有临床和免疫学随访数据,平均随访期为26个月。在随访期间临床病情进展(根据CDC分类)或死亡的患者组,研究开始时的MR显著更高(p < 0.0001)。我们的数据表明,MR与疾病严重程度和进展均相关,且MR与培养物中CD4细胞的耗竭直接相关。(摘要截选至250词)